Custom
Request 

Research Report Details

Author / Researcher : Global Data

Report Statistics

Number Of Pages/Tabs : 454

Number Of Charts : N/A

Published Date : 05/31/2016

Industries : Multiple

Countries : All

Quality Score : 5

Have a question about this report?
24/7 Research Support
Talk to Zursh Analyst
+1 858 522 9998 or Email Us

B-Cell Leukemia Global Clinical Trials Review, H1, 2016
B-Cell Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Leukemia clinical trials scenario.

This report provides top line data relating to the clinical trials on B-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database.

Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

;
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in B-Cell Leukemia Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 451
Abbreviations 451
Definitions 451
Research Methodology 452
Secondary Research 452
About GlobalData 453
Contact Us 453
Disclaimer 453
Source 454

List of Tables
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2016* 6
B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 452

Summary of Source & Methodology

True

GlobalData follows the highest standards when conducting primary and secondary research, including thousands of interviews with senior executives every year, to enable clients to make sound business decisions for their company in complete confidence. 1. 1 million - strong stakeholder group, plus 25,000 interviews annually 2.Rigorous checks on over 25,000 public and proprietary sources 3. Data modeled and forecasted with gold-standard methodology 4. Updated in real time 5. Expert insights and critical analysis from 700 experienced researchers and analysts If you would like to request the complete research methodology of this report or any additional information, please send us an email to reports @zursh.com

Download additional documents & original sources used by researcher/publisher to support the report data

Download Documents
No documents available for download

Zursh quality control analysts have developed a nice rating algorithm to independently and objectively evaluate the quality of this report.

Quality Score : 5
Content 5
Reputation 5
Sources 5
Presentation 5
GlobalData is the premier source of actionable insight into the healthcare industry. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.